OraSure Technologies, Inc. has announced a plan to repurchase up to $40 million of its common stock over the next two years, utilizing cash on hand for the purchases. The Board of Directors will grant management the discretion to determine the amount and timing of these repurchases, which will comply with all relevant securities laws. Additionally, the repurchase program can be altered or stopped at the company's discretion without prior notice. OraSure is dedicated to improving healthcare access and quality through innovative diagnostic tests and sample management solutions, serving a wide range of customers, including healthcare providers, research institutions, and consumers.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.